Condition: Calciphylaxis · Sponsor: Hope Pharmaceuticals
This multicenter, randomized, double-blind, placebo-controlled clinical trial will evaluate the efficacy and safety of intravenous Sodium Thiosulfate Injection for treatment of acute calciphylaxis-associated pain in chronic hemodialysis patients.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Mayo Clinic | Jacksonville, Florida, United States | — |
| Northwestern University Hospital | Chicago, Illinois, United States | — |
| Loyola University Medical Center | Maywood, Illinois, United States | — |
| University of Iowa Hospitals and Clinics | Iowa City, Iowa, United States | — |
| Massachusetts General Hospital | Boston, Massachusetts, United States | — |
| Veterans Administration Medical Center | Albany, New York, United States | — |
| The Icahn School of Medicine at Mount Sinai Hospital | New York, New York, United States | — |
| Sanford Health | Fargo, North Dakota, United States | — |
| Cleveland Clinic | Cleveland, Ohio, United States | — |
| Rhode Island Hospital | Providence, Rhode Island, United States | — |
| University of Virginia Health System | Charlottesville, Virginia, United States | — |
| Veterans Administration Medical Center | Salem, Virginia, United States | — |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03150420